Major German Consumer Test Criticizes Private Health Insurance: Industry Fights Back

A recent investigation by Stiftung Warentest, Germany's leading consumer organization, has ignited a fierce debate within the health insurance sector. The study evaluated 1,245 private health insurance (Private Krankenversicherung or PKV) tariff combinations and delivered a startling verdict: two-thirds were deemed "inadequate." The primary criticisms centered on high deductibles (Selbstbehalte) and significant coverage gaps. However, the German Association of Private Health Insurance (PKV-Verband) and industry experts have launched a robust defense, accusing the test of methodological flaws and a distorted portrayal of the PKV system's value.

The Core of the Controversy: The GKV Benchmark

Stiftung Warentest's fundamental criterion for a positive rating was that a PKV plan must offer "comprehensive protection at least equivalent to the level of statutory health insurance (Gesetzliche Krankenversicherung or GKV)" with an annual deductible not exceeding 660 euros. Only 384 tariffs met this standard.

The PKV-Verband argues this benchmark is fundamentally flawed. In a statement, they countered: "What the testers identify as a supposed weakness in the other tariffs is, in truth, a great strength of PKV: namely, the possibility to choose health protection according to personal needs." They contend that the test ignored key PKV advantages, such as shorter waiting times for specialist appointments, higher doctor remuneration (often leading to more attentive care), and the system's core principle of customizable coverage.

"The standard for evaluation is essentially the benefit scope of the GKV," the association explained. "Simplified: only PKV tariffs that achieved at least GKV benefits were rated as good or very good. This standard is skewed because it omits services that are not paid for in the GKV but are almost always included in the PKV."

The Premium Forecast Debate: A "Cost Trap" in Old Age?

A central point of contention is the test's long-term premium prognosis. Stiftung Warentest warned that PKV costs could become a "cost trap" in retirement, projecting future increases based on the average premium growth of the past 20 years (3.1%).

The PKV-Verband calls these forecasts unreliable and misleading. They highlight a critical omission: a direct long-term cost comparison with the GKV. "If one applies the same calculation method to the GKV," the association emphasizes, "using the Stiftung Warentest logic, you would arrive at a monthly contribution of almost 1,840 euros in 30 years." They note that the GKV's average annual contribution increase over the past two decades was actually higher, at 3.8%.

PKV-Verband director Florian Reuther criticized the omission: "It is precisely in the assessment of contribution stability that Stiftung Warentest omits the long-term comparison with the GKV. Only the PKV makes provision with its contributions for the rising costs of demographic change. The warnings about sharply rising contribution rates in the GKV are completely ignored by the testers." He added that the PKV has built-in mechanisms, like aging reserves (Altersrückstellungen), designed to stabilize premiums over a policyholder's lifetime.

High Customer Satisfaction vs. Test Ratings

Despite the test's critical findings, industry data points to high user satisfaction. A recent Allensbach survey found that 95% of privately insured individuals are satisfied with their health insurance, compared to 73% of those in the public system. The PKV-Verband underscores that 84% of PKV customers are also satisfied with the price-performance ratio of their plans.

Expert Criticism: A Flawed Comparison of Two Different Systems

The criticism extends beyond the industry association. Sven Hennig, a broker specializing in private health insurance, published scathing critique on his blog. He questions the test's credibility, stating it has "finally lost any and all credibility." Hennig's core argument is that comparing the GKV and PKV is like comparing apples and oranges—they are two fundamentally different systems with different principles (solidarity vs. risk-based) and service spectra.

"I am not sure if Stiftung Warentest here consciously and intentionally wants to let readers run into ruin, or if it is simply sheer ignorance of what was tested here," Hennig writes. He warns that choosing a PKV plan based solely on price is a mistake, as the true value lies in the tailored coverage and service quality.

Key Takeaways for Consumers

This debate highlights crucial points for anyone considering German health insurance:

  1. Understand the Systems: The GKV (like a broader, solidarity-based system) and PKV (comparable to comprehensive, customizable US private plans) serve different needs and follow different logics.
  2. Look Beyond Premiums: The cheapest plan is rarely the best. Evaluate coverage depth, service quality (doctor access, hospital choice), exclusions, and long-term cost containment features.
  3. Seek Independent Advice: Navigating PKV options is complex. Consult an independent broker (Versicherungsmakler) who is obligated to act in your interest, not tied to a specific company.
  4. Consider the Long Term: When comparing costs, project both PKV and GKV contributions over decades, considering mechanisms like the PKV's aging reserves and the GKV's dependency on future demographic and political decisions.

The Stiftung Warentest study has undoubtedly raised important questions about transparency and value in the PKV market. However, the strong industry pushback underscores that the evaluation of health insurance is multifaceted. A truly informed decision requires looking past simplified ratings and understanding the trade-offs between standardization, customization, cost, and care in both the German public and private health insurance landscapes.